Navigation Links
Nobelist James Watson proposes an unconventional view of type 2 diabetes causation
Date:2/27/2014

Cold Spring Harbor, NY At 85, Nobel laureate James D. Watson, the co-discoverer of the double-helix structure of DNA, continues to advance intriguing scientific ideas. His latest, a hypothesis on the causation of type 2 diabetes, is to appear 7 pm Thursday US time in the online pages of The Lancet, the prestigious British medical journal.

Watson's hypothesis, which is featured as the Lancet cover story in the U.S. print edition dated March 1-7, 2014, suggests that diabetes, dementias, cardiovascular disease, and some cancers are linked to a failure to generate sufficient biological oxidants, called reactive oxygen species (ROS). Watson also argues the case for a better understanding of the role of exercise in helping to remedy this deficiency.

"The prevalent view of type 2 diabetes," Dr. Watson says, "is that an excess of intracellular oxidation causes inflammation, which in turn kills cells in pancreatic tissue." Proper function of those cells, it is well understood, is critical for the maintenance of normal blood glucose levels.

Over the last several years Watson has been puzzling out an alternative view, based on facts reported in the peer-reviewed literature of medicine and molecular biology. (He makes clear that he is not a medical doctor, rather a student of science.) He does not question that pancreatic tissue in people with type 2 diabetes is indeed inflamed. But he does present a novel theory of why. "The fundamental cause, I suggest, is a lack of biological oxidants, not an excess," he says.

For years, Watson knew, doctors have been telling patients with incipient type 2 diabetes those with high blood sugar levels -- to exercise, often before putting them on a well-proven glucose-lowering drug regimen such as Metformin. Exercise seemed to Watson the key to the puzzle: what was it about exercise that served to benefit people with high blood sugar?

There were important clues, he specul
'/>"/>

Contact: Peter Tarr
tarr@cshl.edu
516-367-5055
Cold Spring Harbor Laboratory
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Medical Tourism: Uncharted Territory for Patients James Goldberg, Author of the American Medical Money Machine, Is Offering a New Consulting Service to Medical Patients Considering “Medical Tourism” Treatment
2. James George, MD: 2012 ASH Wallace H. Coulter Award for Lifetime Achievement in Hematology
3. Before Skyfall: 46 years of violence in James Bond movies
4. NAI Fellows Robert Langer, Leroy Hood and Member James Wynne receive US National Medals
5. Nobel laureate James Watson publishes novel hypothesis on curing late-stage cancers
6. Driving While Drowsy in Buffalo: Lawyer James E. Morris Urges Motorists To Wake Up to the Facts
7. Dr. James Wanless on Tarot, Kathi Kennedi on Hypno-Reiki, Nina Rehzats & Teresa Figueroa on Quantum Healing, Suzy Prudden on Making Money on Dr. Carol Francis Radio Show
8. Eldon James Highlights Eco-Friendly Tubing and Fitting Assemblies at MedTec Europe
9. A-lign Senior Consultant James McAllister Receives QSA Certification
10. Complete Currency Trader: Review Of James Edward's Advanced Forex Trading Course Released
11. Brain researcher James Poulet receives the 2013 Paul Ehrlich Prize for Young Researchers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... ... August 03, 2015 , ... ... solutions for drugs, biologics and consumer health products, today welcomed the announcement by ... OPKO’s New Drug Application for a new treatment for chronic kidney disease (CKD) ...
(Date:8/3/2015)... CA (PRWEB) , ... August 03, 2015 , ... ... suffering from ALS and amputation , AUGUST 3, 2015 – Since winning a ... in March 2015, Not Impossible – an organization whose mission is to develop ...
(Date:8/3/2015)... ... August 03, 2015 , ... Results of a ... for Healthcare Research and Policy Analysis show widespread support for the U.S. Affordable ... agreed or strongly agreed that the controversial law passed in 2010 had “more ...
(Date:8/3/2015)... , ... August 03, 2015 , ... ... National Forest, to Ahjumawi Lava Springs, California’s northernmost and among its least visited ... untapped ground water aquifers, whose main outflow is at Ahjumawi Lava Springs, part ...
(Date:8/3/2015)... (PRWEB) , ... August 03, 2015 , ... A July ... Injection of Stem Cells Found to Release Natural Painkiller That Can Last 'For Five ... patients. According to the report, the new study showed that harvesting stem cell-rich bone ...
Breaking Medicine News(10 mins):Health News:Catalent’s OptiShell™ Technology is Delivery Platform for OPKO Health’s New Chronic Kidney Disease Treatment 2Health News:Catalent’s OptiShell™ Technology is Delivery Platform for OPKO Health’s New Chronic Kidney Disease Treatment 3Health News:Not Impossible Earns Top Awards for Technologies Benefiting Humanity 2Health News:Not Impossible Earns Top Awards for Technologies Benefiting Humanity 3Health News:Not Impossible Earns Top Awards for Technologies Benefiting Humanity 4Health News:Survey Finds Support for the Affordable Care Act Among Physician Leaders 2Health News:Survey Finds Support for the Affordable Care Act Among Physician Leaders 3Health News:Medicine Lake Aquifer could ease California drought says fresh water advocate Sharon Kleyne – but is this necessary? 2Health News:Medicine Lake Aquifer could ease California drought says fresh water advocate Sharon Kleyne – but is this necessary? 3Health News:Medicine Lake Aquifer could ease California drought says fresh water advocate Sharon Kleyne – but is this necessary? 4Health News:Los Angeles Spine Surgeon Gives Insight into How Stem Cells Can Relieve Back Pain 2Health News:Los Angeles Spine Surgeon Gives Insight into How Stem Cells Can Relieve Back Pain 3
... Jan. 12 David M. Klein, Ph.D., original co-owner ... Arizona and a developer of that national brand, has ... centers to Arizona.Natural Weight(TM) For Optimized Living is a ... that enables you to become healthier at any weight, ...
... FRANCISCO, Jan. 12 Within health care, dermatology,professionals play ... , The Dermatology Nurses, Association ... practice in a variety,of learning formats and the opportunity ... annual conference slated for March,4-7 at the Hilton San ...
... Also Appoints Industry Veteran Steve Shulman to BoardHOUSTON, ... first and largest provider of outsourced medical implantable ... announced today that its board of directors has ... The company announced the appointment following its second ...
... providing high-quality speech pathology services, according to University ... , Completed through UQ,s School of Health and ... language disorders could be validly and reliably assessed ... , "Having worked clinically with people living with ...
... 12 A partnership between Command Spanish(R), Inc. and ... providers of nursing education, makes the two companies co-providers ... instruction being provided by the two companies allows nurses ... occupational Spanish. Two new courses are available online to ...
... Inc. (Nasdaq: ALXN ), today announced that ... fourth quarter and full year ended December 31, 2008 ... open. Following the release of the financials, Alexion management ... on Thursday, February 12, 2009, at 10:00 a.m. Eastern ...
Cached Medicine News:Health News:Dr. David M. Klein, Innovator of Smart for Life in Arizona, Brings New Weight Management and Wellness Concept to Arizona 2Health News:Dr. David M. Klein, Innovator of Smart for Life in Arizona, Brings New Weight Management and Wellness Concept to Arizona 3Health News:Hop the Trolley for DNA's 27th Annual Conference 2Health News:Access MediQuip Appoints Former Priority Healthcare CEO to Chairman of the Board 2Health News:Access MediQuip Appoints Former Priority Healthcare CEO to Chairman of the Board 3Health News:UQ research finds speech disorders can be assessed from a distance 2Health News:Nurses: Command Spanish Online's Occupational Spanish Language Course Accepted for Credit by the American Nurses Credentialing Center (ANCC) 2
(Date:8/3/2015)... 3, 2015  EnteroMedics Inc. (NASDAQ: ETRM ), the ... obesity, metabolic diseases and other gastrointestinal disorders, today announced ... to the Board of Directors, effective July 31, 2015.  ... until the 2018 annual meeting or until her successor ... served in an executive capacity in the healthcare industry ...
(Date:8/3/2015)... 2015  Sorrento Therapeutics, Inc. (NASDAQ: SRNE ; ... exclusive licensing agreement to develop and commercialize multiple prespecified ... a holding company for premier antibody development and manufacturing ... Under the terms of the agreement, Sorrento will ... the North American, European and Japanese market. Each of ...
(Date:8/2/2015)... , August 3, 2015 Mandatory ... Dechra Pharmaceuticals PLC ("Dechra" or the "Company") is pleased ... agreement ("SPA") with Mr. Marijan Han žeković to ... in Genera d.d. ("Genera"), a Croatian listed pharmaceutical business. ... share, which is equivalent to €51.4 million for the ...
Breaking Medicine Technology:EnteroMedics Announces Appointment of Lori C. McDougal to the Board of Directors 2EnteroMedics Announces Appointment of Lori C. McDougal to the Board of Directors 3Sorrento In-Licenses Four Late-Stage Clinical Biobetter and Biosimilar Antibodies 2Sorrento In-Licenses Four Late-Stage Clinical Biobetter and Biosimilar Antibodies 3Sorrento In-Licenses Four Late-Stage Clinical Biobetter and Biosimilar Antibodies 4Dechra to Acquire 63.3% Shareholding (£19.4m) in Genera d.d. Croatia 2Dechra to Acquire 63.3% Shareholding (£19.4m) in Genera d.d. Croatia 3Dechra to Acquire 63.3% Shareholding (£19.4m) in Genera d.d. Croatia 4Dechra to Acquire 63.3% Shareholding (£19.4m) in Genera d.d. Croatia 5
... NVAX ), a clinical-stage vaccine company, announced today ... presenting at the ROTH 23rd Annual OC Growth Stock Conference ... The Ritz Carlton, Laguna Niguel, CA.  A live audio-only webcast ... website at www.novavax.com under Investors/Events, and a replay ...
... and LONDON, March 11, 2011 Tolerx, ... 3 DEFEND-1 study of otelixizumab, an investigational humanized anti-CD3 ... of change in C-peptide at month 12 in patients ... Following preliminary review of the data, no new or ...
Cached Medicine Technology:Tolerx and GlaxoSmithKline Announce Phase 3 Defend-1 Study of Otelixizumab in Type 1 Diabetes Did Not Meet Its Primary Endpoint 2Tolerx and GlaxoSmithKline Announce Phase 3 Defend-1 Study of Otelixizumab in Type 1 Diabetes Did Not Meet Its Primary Endpoint 3Tolerx and GlaxoSmithKline Announce Phase 3 Defend-1 Study of Otelixizumab in Type 1 Diabetes Did Not Meet Its Primary Endpoint 4
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: